Abstract
Neuromyotonia is characterized by spontaneous and continuous muscle fibre activity leading to muscle cramps, pseudomyotonia, myokymia and weakness. Electromyographic recordings show typical findings. An auto-immune mechanism has been suggested in at least a subset of patients. Various therapies have been tried with different outcome. A patient with neuromyotonia responding well to high-dose immunoglobulin treatment is presented.
MeSH terms
-
Autoimmunity
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Electromyography
-
Humans
-
Immunoglobulins, Intravenous / administration & dosage
-
Immunoglobulins, Intravenous / therapeutic use*
-
Isaacs Syndrome / drug therapy*
-
Isaacs Syndrome / etiology
-
Isaacs Syndrome / immunology
-
Isaacs Syndrome / physiopathology
-
Male
-
Middle Aged
-
Polyneuropathies / complications
-
Remission Induction
Substances
-
Immunoglobulins, Intravenous